Pulmonary Thromboembolisms
|
0.310 |
Biomarker
|
disease |
BEFREE |
The efficacy of reteplase against PTE in comparison to alteplase was clarified for the first time, and this PTE model could be further applied to studies of novel thrombolytic therapies.
|
30464403 |
2018 |
Pulmonary Thromboembolisms
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child.
|
19415734 |
2009 |
Pulmonary Thromboembolisms
|
0.310 |
Biomarker
|
disease |
CTD_human |
Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child.
|
19415734 |
2009 |
Pulmonary Thromboembolisms
|
0.310 |
Biomarker
|
disease |
CTD_human |
Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.
|
9199818 |
1997 |
Pulmonary Thromboembolisms
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.
|
9266785 |
1997 |
Pulmonary Thromboembolisms
|
0.310 |
Biomarker
|
disease |
CTD_human |
Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.
|
9266785 |
1997 |
Pulmonary Thromboembolisms
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.
|
9199818 |
1997 |
Pulmonary Thromboembolisms
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
|
8082347 |
1994 |
Pulmonary Thromboembolisms
|
0.310 |
Biomarker
|
disease |
CTD_human |
Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
|
8082347 |
1994 |
Pulmonary Thromboembolisms
|
0.310 |
Biomarker
|
disease |
CTD_human |
[Dissolution of a right cardiac migrant thromboembolus in pulmonary embolism after treatment with rt-PA. Report of a successfully treated case].
|
8451030 |
1993 |
Pulmonary Thromboembolisms
|
0.310 |
Therapeutic
|
disease |
CTD_human |
[Dissolution of a right cardiac migrant thromboembolus in pulmonary embolism after treatment with rt-PA. Report of a successfully treated case].
|
8451030 |
1993 |
Pulmonary Thromboembolisms
|
0.310 |
Biomarker
|
disease |
CTD_human |
Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.
|
1899825 |
1991 |
Pulmonary Thromboembolisms
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.
|
1899825 |
1991 |
Pulmonary Thromboembolisms
|
0.310 |
Therapeutic
|
disease |
CTD_human |
A new manifestation and treatment alternative for heparin-induced thrombosis.
|
2123154 |
1990 |
Pulmonary Thromboembolisms
|
0.310 |
Biomarker
|
disease |
CTD_human |
A new manifestation and treatment alternative for heparin-induced thrombosis.
|
2123154 |
1990 |
Pulmonary Thromboembolisms
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning.
|
3122266 |
1988 |
Pulmonary Thromboembolisms
|
0.310 |
Biomarker
|
disease |
CTD_human |
Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning.
|
3122266 |
1988 |
Pulmonary Thromboembolisms
|
0.310 |
Biomarker
|
disease |
CTD_human |
Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.
|
3105914 |
1987 |
Pulmonary Thromboembolisms
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.
|
3105914 |
1987 |